Partner Harvey Kesner Represents ChromaDex on $2M Registered Direct Offering of Common Stock and Warrants
Press Release – New York, NY – November 17, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented ChromaDex Corp. (OTCQX: CDXC) (the “Company”), an innovator of proprietary health, wellness, and nutritional ingredients to create science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products, in connection with its $2,000,000 registered direct offering.
The Company sold an aggregate of 200,000 units at a purchase price of $10.00 per unit, with each unit consisting of eight shares of the Company’s common stock and a warrant to purchase four shares of common stock at $1.50 per share.
The Sichenzia Ross Friedman Ference LLP team was led by Partner Harvey Kesner and Associates Avital Even-Shoshan and Wei Wang.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Medical Marijuana Dispensary Business Project 1493, LLC Announces Share Exchange Agreement with Public Entity & Simultaneous $3.3 Million PIPE Financing - June 16, 2017
- Sichenzia Ross Ference Kesner LLP Represents Immuron Limited on $6.1M IPO and NASDAQ listing - June 15, 2017
- Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc. - June 8, 2017